Tag: TARE
EmboCept® S degradable starch microspheres show high efficacy and good tolerability...
This advertorial is sponsored by Sirtex.
Interventional radiologists Thomas Albrecht (Vivantes Clinic Neukölln, Berlin, Germany) and Roberto Iezzi (Policlinico Universitario Fondazione Agostino Gemelli, Rome, Italy)...
‘A new narrative’: TACE in the age of Y90 and immunotherapy
Hotly debated across the Society of Interventional Oncology (SIO; 25–29 January 2024, Long Beach, USA) annual conference programme, speakers took to the stage to...
IO of the past, present and future: presentation predicts what is...
Setting the audiences sights on the horizon at the 2023 Global Embolization Oncology Symposium (GEST, 18–21 May, New York City, USA) yesterday, Daniel Sze...
The rebirth of transarterial radioembolization and the crucial role of the...
After the disappointment of a few failed randomised controlled trials (RCTs), transarterial radioembolization (TARE) is finally back in the spotlight. And interventional radiologists (IRs)...
TriNav receives CMS approval for transitional pass-through payment status
TriSalus Life Sciences (formerly Surefire Medical) has announced that the Centers for Medicare and Medicaid Services (CMS) granted approval for transitional pass-through (TPT) payment...
